Project rtor BIO-AMT-1021: development of animal models for evaluation of medical countermeasures for sars-COV-2
Ended Awarded Last action
- Contract number
- 75A50120F33002
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $4,711,753
Award facts
- Opportunity
-
- BARDA Biological Animal Model Development Pre-Solicitation · Posted Jan 8, 2016
- Contract value 100% obligated
- $4,711,752.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,363,328 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Exercise an Option | $2,177,532 | |
| Exercise an Option | $2,958,794 | |
| Original award | $938,755 |
About this award
This is a $4,711,752.76 cost-plus-fixed-fee delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The order is part of the Biomedical Advanced Research and Development Authority's (BARDA) Biological Animal Model Development 2017-2022 contract vehicle and involves the development of animal models for evaluating medical countermeasures against SARS-CoV-2. This work supports the government's efforts to advance treatments and cures for COVID-19. The contract does not have a set-aside designation. Lovelace Biomedical Research Institute has a history of providing a range of preclinical research services, including animal studies, to federal agencies such as the National Institutes of Health, Department of Defense, and Food and Drug Administration.
Quick answers
Who was awarded contract 75A50120F33002?
75A50120F33002 was awarded to Lovelace Biomedical Research Institute by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on March 30, 2020.
How much is contract 75A50120F33002 worth?
The government has obligated $4,711,753 on 75A50120F33002.
Is contract 75A50120F33002 an order under another contract?
Yes. 75A50120F33002 is a delivery order under HHSO100201700023I, an indefinite delivery contract, on BARDA Biological Animal Model Development 2017-2022.
Was contract 75A50120F33002 competed?
The extent of competition for 75A50120F33002 was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award